*NEW CASES OF EBOLA IN LIBERIA AFTER TWO MONTHS POINT TO BIOTERRORISM
*HEALTH OFFICIALS CANNOT FIND CAUSE
*INDEX PATIENT, A BOY, HAD NO LINK TO A CARRIER OF ANOTHER VIRUS, ADMITS WHO
* BOY HAS GONE ON TO INFECT FAMILY MEMBERS
*MERCK AND GSK EBOLA VACCINE TRIAL STARTED IN LIBERIA LAST WEEK
Health officials cannot discover the cause of three new cases of Ebola confirmed in Liberia two months after the country was declared free of the deadly virus.
The original new case, a boy of ten, had no known history of contact with a survivor or having been at the funeral of an Ebola victim, reports The Guardian.
WHO’s Ebola response chief, Bruce Aylward, said “initial investigations had not produced a confirmed link between the 10-year-old and another carrier of the virus, as health officials tried to figure out the origins of the case.”
The boy appears to have been the source of infection for other members of his family. But how he himself got infected is a mystery/
The mysterious flare up of Ebola in Liberia could be explained by bioterrorism, which has the same irregular features as MERS.
Australian Infectious diseases epidemiologist Professor Raina MacIntyre from The School of Public Health And Community Medicine at UNSW, analysed the epidemiologic features of MERS-Cov compared to SARS and concluded many of the features could not be explained by known principles of epidemiology.
“It is a mystery why this virus, which has low apparent infectiousness has persisted for so long when a consistent source of infections has not been identified.” says MacIntyre. “Infections cannot materialize from thin air. Human beings are being infected from a source, either other humans or a non-human source. A non-human source could be an animal source or deliberate release,” she said.
A large-scale human trial of Merck and GSK Ebola vaccines got under way in Liberia’s capital on November 14th.
During a Merck Ebola vaccine trial in Guinea, subjects contracted Ebola from the vaccine. Trial results published online state that the vaccines caused Ebola.
“As of July 20, 2015, a total of 43 serious adverse events had been documented among eligible and consenting trial participants, including 27 confirmed cases of Ebola virus disease (see appendix). Apart from Ebola virus disease, the three most common serious adverse events were suspected, unconfirmed Ebola virus disease (three cases), episodes of febrile illness (three cases), and road traffic accidents (three cases). 16 deaths occurred: 15 from Ebola virus disease and one from cardiac arrest.”
“Adverse events” is standard terminology for reporting a side effect of a drug or vaccine.
A Merck HIV vaccine was found to give people AIDS during a trial, which was susbsequently abandoned.
Furthermore, the Ebola vaccine study did not use a standard methodology (a control group was dropped in the middle) and the results recorded seem to be incomplete, and the analysis faulty.